Bioport Closed Blood Sampling System, Model BT XXXXXX- BP
510(k) K983372
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK983372 | Date5 Feb 1999 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DRS
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.2850
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 27 Sep 2026
The Bioport Closed Blood Sampling System, Model BT XXXXXX- BP is a transducer, blood-pressure, extravascular device used for cardiovascular applications. It received FDA 510(k) clearance as substantially equivalent to a predicate device on February 5, 1999.
The device is manufactured by Sunscope Intl., Inc. and is identified by the product code DRS and regulation number 870.2850. It is supplied as a single unit and is intended for use in clinical settings where extravascular blood pressure monitoring is required.
Other devices from Sunscope Intl., Inc.
Questions
AI-generated answers, 27 Sep 2026
What is the Bioport Closed Blood Sampling System BT XXXXXX-BP used for?
The Bioport Closed Blood Sampling System Model BT XXXXXX-BP is a transducer designed for extravascular blood-pressure monitoring in cardiovascular applications, as indicated by its product code DRS and regulation number 870.2850.
How is the Bioport Closed Blood Sampling System BT XXXXXX-BP supplied and is it reusable?
The device is supplied as a single unit and is intended for single use in clinical settings, based on its description as a single-unit extravascular blood-pressure transducer with no mention of reprocessing or reuse.
What regulatory pathway was used for the Bioport Closed Blood Sampling System BT XXXXXX-BP?
The device received FDA 510(k) clearance on February 5, 1999, under submission K983372, determined to be substantially equivalent to a predicate device.